<unk>  is a human immunodeficiency virus nucleoside analog reverse transcriptase inhibitor, human immunodeficiency virus 1 non-nucleoside analog reverse transcriptase inhibitor that is FDA approved for the treatment of HIV-1 infection. There is a Black Box Warning for this drug as shown here.  Common adverse reactions include rash, diarrhea, nausea, decreased bone mineral density, dizziness, headache, anxiety, depression, sleep disorder, increased creatine kinase level, sinusitis, upper respiratory tract infection, fatigue.
Efavirenz, emtricitabine and tenofovir disoproxil fumarate
Emtricitabine, rilpivirine hydrochloride, and tenofovir alafenamide fumarate
Emtricitabine and tenofovir alafenamide fumarate
Elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide
Emtricitabine and tenofovir disoproxil fumarate
Dolutegravir / rilpivirine
Atazanavir and cobicistat
Bictegravir / emtricitabine / tenofovir alafenamide